LEADERSHIP VACUUM WEIGHS ON COLOPLAST (BUY; 46% UPSIDE)
06/06/25 -" At the outset, and at a risk of repeating ourselves, Coloplast (BUY; Denmark) is a top-tier MedTech play. A fact validated by a top quartile position among AV MedTechs on the return metrics as well ..."
Pages
65
Language
English
Published on
06/06/25
You may also be interested by these reports :
10/06/25
Due to the weaker performance in China and the US, which together account for over 35% of sales, we have revised our estimates downwards. However, we ...
06/06/25
At the outset, and at a risk of repeating ourselves, Coloplast (BUY; Denmark) is a top-tier MedTech play. A fact validated by a top quartile position ...
06/06/25
We have updated our estimates, incorporating the latest figures. We now anticipate increased profitability, driven by the enhanced effectiveness of ...
04/06/25
Despite the challenges outlined in the EPS section, which have led to a significant reduction in our target price, we continue to strongly recommend ...